Notify me when Najat Khan files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | CEO and President, Director | $7,993,436 | -$750,765 | -8.6% | 17 Feb 2026 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|